Cargando…
An Unnecessary Pain: Using Pharmacogenetics for Statin-related Skeletal Muscle Toxicity
Statins are an important class of medications in reducing the risk of cardiovascular events as well as overall mortality. However, a well-known adverse effect of statins is skeletal muscle toxicity, which may lead to abrupt discontinuation of the statin. In turn, patients may miss out on the benefit...
Autor principal: | Alzghari, Saeed K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029739/ https://www.ncbi.nlm.nih.gov/pubmed/29974012 http://dx.doi.org/10.7759/cureus.2557 |
Ejemplares similares
-
Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects
por: Ramakumari, Nuthalapati, et al.
Publicado: (2018) -
The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety
por: Ching, Nathan R, et al.
Publicado: (2018) -
Prevalence of Self-Reported Muscle Pain Among Statin Users From National Guard Hospital, Riyadh
por: Suliman, Ihab, et al.
Publicado: (2022) -
Proposal for a Pharmacogenetic Decision Algorithm
por: Alzghari, Saeed K, et al.
Publicado: (2017) -
The Current Landscape of Marijuana and Pharmacogenetics
por: Rambaran, Kerry Anne, et al.
Publicado: (2017)